4 resultaten
At least 90% of the subjects, with 95% confidence, will tolerate the test formula.
Ons doel is om de effectiviteit van optimaal gedoseerde MTX versus placebo te onderzoeken in patienten met recent gediagnosticeerd PMR (volgens de 2012 EULAR/ACR criteria).
As this is an explorative design, no formal hypothesis is made. However, our sample size is based on a difference of 2.5% or more in cumulative incidence of serious infections when continuing IA, hypothesizing that patients who continue their IA in…
The main hypothesis is that specific mechanisms of action and level of immunosuppressive medication is the most important determinant of SARS-CoV-2 immunity after vaccination or infection in ISP patients.